Inventor
SIMON BARRY J
US16 patents
⚠️ This page may combine multiple inventors who share the name “SIMON BARRY J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NANTKWEST INC
10 patentsUS11207350B2Dec 28, 2021
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
NANTKWEST INC11 citations93
US10456420B2Oct 29, 2019
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
NANTKWEST INC19 citations93
US10258649B2Apr 16, 2019
Tumoricidal and antimicrobial compositions and methods
NANTKWEST INC9 citations92
US11000550B2May 11, 2021
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
NANTKWEST INC6 citations83
US10736921B2Aug 11, 2020
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
NANTKWEST INC5 citations83
US10517895B2Dec 31, 2019
Tumoricidal and antimicrobial compositions and methods
NANTKWEST INC5 citations83
US11304977B2Apr 19, 2022
Tumoricidal and antimicrobial compositions and methods
NANTKWEST INC0 citations62
US11213547B2Jan 4, 2022
Tumoricidal and antimicrobial compositions and methods
NANTKWEST INC0 citations62
US10772912B2Sep 15, 2020
Tumoricidal and antimicrobial composition
NANTKWEST INC0 citations51
US10646516B2May 12, 2020
Tumoricidal and antimicrobial compositions and methods
NANTKWEST INC0 citations51
IMMUNITYBIO INC
3 patentsUS12384852B2Aug 12, 2025
Genetically modified NK-92 cells having a safety switch
IMMUNITYBIO INC2 citations70
US12064450B2Aug 20, 2024
Tumoricidal and antimicrobial compositions and methods
IMMUNITYBIO INC0 citations62
US11975027B2May 7, 2024
Tumoricidal and antimicrobial compositions and methods
IMMUNITYBIO INC0 citations62